Abstract
The Janus kinases (JAKs) enzymes are a family of cytosolic tyrosine kinases that are associated with membrane receptors and play a critical role in the rapid transduction of signals from cell surface to the nucleus. There are four different tyrosine kinases (Tyk2, Jak1, Jak2, Jak3) that share significant structural homology with each other. Binding of cytokines or growth factors to their cognate receptor activate JAK kinases, which in turn mediate the subsequent tyrosine phosphorylation of STAT proteins. Phosphorylated STAT proteins form dimers, translocate to the nucleus, and bind to specific DNA elements to induce or modulate expression of target genes. Aberrant activation of JAK kinases has been implicated in many hematological malignancies and carcinomas. There is also accumulating evidence that constitutive activation of different Jaks and Stats mediate neoplastic transformation and promote abnormal cell proliferation in various malignancies. This review will discuss the role of various Jak-kinase dependent signal transduction pathways in malignancies as well as therapeutic implications of the recent advances in the field.
Keywords: Janus kinase, signal transducer and activator of transcription, suppressors of cytokine signaling, cytokines, signal transduction pathways
Current Enzyme Inhibition
Title: JAK Family of Tyrosine Kinases: Its Functions and Alterations in Human Cancer
Volume: 2 Issue: 2
Author(s): Shahab Uddin, Azhar R. Hussain and Khawla S. Al-Kuraya
Affiliation:
Keywords: Janus kinase, signal transducer and activator of transcription, suppressors of cytokine signaling, cytokines, signal transduction pathways
Abstract: The Janus kinases (JAKs) enzymes are a family of cytosolic tyrosine kinases that are associated with membrane receptors and play a critical role in the rapid transduction of signals from cell surface to the nucleus. There are four different tyrosine kinases (Tyk2, Jak1, Jak2, Jak3) that share significant structural homology with each other. Binding of cytokines or growth factors to their cognate receptor activate JAK kinases, which in turn mediate the subsequent tyrosine phosphorylation of STAT proteins. Phosphorylated STAT proteins form dimers, translocate to the nucleus, and bind to specific DNA elements to induce or modulate expression of target genes. Aberrant activation of JAK kinases has been implicated in many hematological malignancies and carcinomas. There is also accumulating evidence that constitutive activation of different Jaks and Stats mediate neoplastic transformation and promote abnormal cell proliferation in various malignancies. This review will discuss the role of various Jak-kinase dependent signal transduction pathways in malignancies as well as therapeutic implications of the recent advances in the field.
Export Options
About this article
Cite this article as:
Uddin Shahab, Hussain R. Azhar and Al-Kuraya S. Khawla, JAK Family of Tyrosine Kinases: Its Functions and Alterations in Human Cancer, Current Enzyme Inhibition 2006; 2 (2) . https://dx.doi.org/10.2174/157340806776818766
DOI https://dx.doi.org/10.2174/157340806776818766 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Activation of Myosin Phosphatase by Epigallocatechin-Gallate Sensitizes THP-1 Leukemic Cells to Daunorubicin
Anti-Cancer Agents in Medicinal Chemistry Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma
Anti-Cancer Agents in Medicinal Chemistry Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Lymphoproliferative Lesions in IgG4-Related Disease
Current Immunology Reviews (Discontinued) On the Power of Additional and Complex Chromosomal Aberrations in CML
Current Genomics Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
Current Enzyme Inhibition Phosphoproteomics as a Promising Tool for Broadening the Analysis of Clinical Samples and for the Fight Against Cancer Disease
Current Pharmaceutical Analysis Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome
Current Molecular Medicine Monoclonal Antibodies: New Therapeutic Agents for Autoimmune Hemolytic Anemia?
Endocrine, Metabolic & Immune Disorders - Drug Targets MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets Low-Density Lipoprotein Cholesterol (LDL-C): How Low?
Current Vascular Pharmacology C-KIT Signaling in Cancer Treatment
Current Pharmaceutical Design Detection of Predictive Markers for Therapeutic Stratification of Salivary Glands Tumors
Current Drug Targets Role of Flavonoids in Future Anticancer Therapy by Eliminating the Cancer Stem Cells
Current Stem Cell Research & Therapy Protective Role of Silymarin in Early Doxorubicin-induced Cardiac Dysfunction in Children with Acute Lymphoblastic Leukemia
Infectious Disorders - Drug Targets Reversal of Resistance to Oxazaphosphorines
Current Cancer Drug Targets Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics
Current Medicinal Chemistry Arginine Deprivation as a Targeted Therapy for Cancer
Current Pharmaceutical Design Maternal Sepsis: Current Approaches to Recognition and Clinical Management
Current Women`s Health Reviews New Insights Toward Nanostructured Drug Delivery of Plant-Derived Polyphenol Compounds: Cancer Treatment and Gene Expression Profiles
Current Cancer Drug Targets